Chemical Structure : Palivizumab
CAS No.: 188039-54-5
货号: PC-Ab1100Not For Human Use, Lab Use Only.
Palivizumab (MEDI-493) is a monoclonal antibody to the RSV F protein that inhibits binding of the virus to cellular receptors. This reduces viral activity and cell-to-cell transmission, and blocks the fusion of infected cells. Palivizumab is directed at an epitope in the A antigenic site of the 'F' protein on the surface of RSV. Palivizumab binds to this epitope, which is highly conserved among different RSV isolates..
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥3580 | In stock | |
5 mg | ¥7580 | In stock | |
10 mg | ¥12800 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Palivizumab (MEDI-493) is a monoclonal antibody to the RSV F protein that inhibits binding of the virus to cellular receptors. This reduces viral activity and cell-to-cell transmission, and blocks the fusion of infected cells. Palivizumab is directed at an epitope in the A antigenic site of the 'F' protein on the surface of RSV. Palivizumab binds to this epitope, which is highly conserved among different RSV isolates.
分子量 | ||
分子式 | Human IgG1-Kappa | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
PBS, pH 7.0 Contains no stabilizers or preservatives |
|
Chemical Name/SMILES |
Palivizumab; Synagis; MEDI-493; 188039-54-5; Anti-RSV fusion protein; Anti-RSV fusion glycoprotein; Anti respiratory syncytial virus fusion protein; Anti-RSV fusion |
1. 1, Johnson S, et al. J Infect Dis. 1997 Nov;176(5):1215-24. 2, Malley R, et al. J Infect Dis. 1998 Dec;178(6):1555-61. 3, Johnson S, et al. J Infect Dis. 1999 Jul;180(1):35-40. 4, Russell AB. Hosp Med. 1999 Dec;60(12):873-7.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright